Dan Florin

SVP Chief Financial Officer at Biomet

Professional Overview
Dan Florin is an accomplished finance executive with extensive experience in the medical device industry. As the SVP Chief Financial Officer at Biomet, he oversees the company's financial operations, strategy, and business development initiatives, playing a pivotal role in driving the organization's growth and profitability.

Experience Summary

Current Role
In his current role as SVP Chief Financial Officer at Biomet, Dan is responsible for managing the company's financial planning, reporting, and strategic decision-making. He leads a team of finance professionals to ensure the effective allocation of resources, implementation of cost-saving measures, and alignment of financial objectives with Biomet's overall business strategy. Under Dan's financial leadership, Biomet has achieved consistent revenue growth and improved operational efficiency.

Career Progression
Prior to joining Biomet, Dan held various finance leadership positions at other leading medical device companies, where he honed his expertise in financial management, strategic planning, and mergers and acquisitions. His career trajectory has been marked by progressive responsibilities and a track record of driving successful financial and operational initiatives.

Academic Background
Dan holds a Bachelor of Science in Accounting from the University of Notre Dame and a Master of Business Administration from the University of Chicago Booth School of Business. He is a Certified Public Accountant (CPA) and has received recognition for his academic achievements and contributions to the finance profession.

Areas of Expertise

• Financial planning and analysis

• Cost optimization and operational efficiency

• Mergers, acquisitions, and integration

• Capital allocation and investment strategies

• Financial reporting and compliance

• Business partnering and strategic decision-making

Professional Impact
During his tenure at Biomet, Dan has played a pivotal role in driving the company's financial performance and positioning it for long-term success. He has led the implementation of advanced financial systems and processes, ensuring timely and accurate reporting, and has been instrumental in securing strategic partnerships and acquisitions that have expanded Biomet's product portfolio and market reach.

Conclusion
With his extensive finance expertise, industry knowledge, and strategic acumen, Dan Florin is a respected leader in the medical device industry. As the SVP Chief Financial Officer at Biomet, he continues to contribute to the company's growth and financial stability, positioning it for continued success in the evolving healthcare landscape.